Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART

Background: Dolutegravir in second-line antiretroviral therapy (ART) is more effective with recycled tenofovir than switching to zidovudine. However, dolutegravir resistance is more frequent in second-line compared to first-line ART. Objectives: We report long-term virologic outcomes from a clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer K. van Heerden, Ying Zhao, Claire M. Keene, Rulan Griesel, Zaayid Omar, René Goliath, Kayla Delaney, Gert van Zyl, Gary Maartens, Graeme Meintjes
Format: Article
Language:English
Published: AOSIS 2025-04-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1677
Tags: Add Tag
No Tags, Be the first to tag this record!